Top Industry Leaders in the Monoclonal Antibody Custom Service Market
Latest Monoclonal Antibody Custom Service Companies Update:
Creative Biolabs (US) partners with Absea (France) to offer a comprehensive range of pre-clinical research services, including custom monoclonal antibody development. (Dec 2023)
Thermo Fisher Scientific (US) acquires Pheno Therapeutics (US), gaining access to its hybridoma library and expertise in high-throughput antibody screening. (Nov 2023)
GenScript (China) forms a strategic alliance with the University of California, San Diego (US) to develop novel antibody-based therapies for cancer. (Oct 2023)
ProMab Biotechnologies (US) launches its ProMab Express service, offering rapid generation of custom monoclonal antibodies within 8 weeks. (Jan 2024)
Abcam (UK) expands its custom antibody conjugation services with the introduction of new labeling options for targeted drug delivery. (Dec 2023)
Envigo (US) opens a new state-of-the-art facility in China to cater to the growing demand for custom antibody production in the Asia Pacific region. (Nov 2023)
List of Monoclonal Antibody Custom Service Key companies in the market
- Thermo Fisher Scientific Inc. (US)
- GenScript (US)
- Abnova Corporation (Taiwan)
- ProteoGenix (France)